Serum Institute Restarts Manufacturing Of COVID-19 Vaccine Covishield

Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.